Press Release Date: Time: Contact: 05 August 2014

First Page		Document Content
Date: 2014-08-05 06:29:50 Department of Health Medicines and Healthcare products Regulatory Agency Pharmacology Research Anticoagulant Faculty of Pharmaceutical Medicine Yellow Card Scheme Pharmaceutical industry Pharmaceutical sciences Clinical research		Press Release Date: Time: Contact: 05 August 2014 Add to Reading List Source URL: www.mhra.gov.uk Download Document from Source Website File Size: 68,21 KB Share Document on Facebook

	UK Royal College and Faculty exams which provide appropriate objective assurance for revalidation We will accept evidence of a pass, within the last five years, in one of the listed exams. This means you will not need to DocID: 1pBq3 - View Document
	Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1112 Patients in Clinical Cancer Trials Understanding, Motivation and Hope TOVE GODSKESEN DocID: 1fLN6 - View Document
	The Faculty of Pharmaceutical Medicine Survey of members on transparency in Clinical Trials Presentation to HRA workshop on clinical trials registration, DocID: 1fEVE - View Document
	Tyrosine kinase inhibitors quantification in human plasma M. Helvenstein1,3, R. Conotte2,3, J-M. Colet2,3, B. Blankert1,3 1Laboratory of Pharmaceutical Analysis, Faculty of medicine and pharmacy, University of Mons, Pla DocID: 1e0aW - View Document
	1. The investigator seeking approval must be a UW faculty member. If the PI for the proposal is not a faculty member (e.g. Senior Fellow) a sponsoring faculty member must be the applicant of record. 1a. Faculty P DocID: 1aLkb - View Document